(Q43782234)

English

Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi

scientific article published on 30 April 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

object named as

Michele Spina

7

1 reference

ORCID Public Data File 2021

Massimo Federico

object named as

Massimo Federico

19

1 reference

ORCID Public Data File 2021

3

object named as

Giuseppe Rossi

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Stefano Luminari

2

object named as

Stefano Luminari

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Francesco Merli

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Caterina Mammi

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Luigi Marcheselli

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Angela Ferrari

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Alessandra Tucci

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Caterina Stelitano

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Isabella Capodanno

10

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Alberto Fragasso

11

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Chiara Bottelli

13

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Elisa Montechiarello

14

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Stefano Fogazzi

15

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Cinzia Lamorgese

16

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Lara Cavalli

17

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Massimo Federico

18

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Fondazione Italiana Linfomi

20

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

38-43

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

Randomized trial of 8-week versus 12-week VNCOP-B plus G-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin's lymphoma patients.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

Management of the frail person with advanced cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

Comprehensive geriatric assessment for older patients with cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

The application of the principles of geriatrics to the management of the older person with cancer

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

Analysis of very elderly (≥80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcome.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

Different age limits for elderly patients with indolent and aggressive non-hodgkin lymphoma and the role of relative survival with increasing age.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

The Influence of advanced age on the treatment and prognosis of diffuse large-cell lymphoma (DLCL).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2013.788176

21 January 2018

Identifiers

10.3109/10428194.2013.788176

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43782234&oldid=2255019735"